← Open Payments lookup

OLIVIA HUNTZINGER: Open Payments

NPI 1508322868 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$918 in 39 payments from 13 companies in 2025. Trend: 2023 $312 · 2024 $485 · 2025 $918

Food & beverage: $918
CompanyPaymentsAmount
ABBVIE INC.10$179
Alkermes, Inc.5$150
E.R. Squibb & Sons, L.L.C.5$137
Janssen Pharmaceuticals, Inc4$102
Otsuka America Pharmaceutical, Inc.3$83
Lundbeck LLC3$75
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$64
Vanda Pharmaceuticals Inc.1$39
Almatica Pharma LLC1$20
Otsuka Pharmaceutical Development & Commercialization, Inc.1$20

Products named: VRAYLAR, REXULTI, ARISTADA, COBENFY, CAPLYTA, INVEGA SUSTENNA, SPRAVATO, FANAPT.

Industry payments across NV — which companies pay providers there.